Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients

被引:10
作者
Brennan, DC
Garlock, KA
Lippmann, BJ
Buller, RS
GaudreaultKeener, M
Lowell, JA
Miller, SB
Shenoy, S
Howard, TK
Storch, GA
机构
[1] WASHINGTON UNIV, SCH MED, ST LOUIS, MO USA
[2] BARNES HOSP, ST LOUIS, MO 63110 USA
关键词
D O I
10.1016/S0041-1345(96)00143-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:809 / 811
页数:3
相关论文
共 3 条
[1]   MANAGEMENT AND PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER RENAL-TRANSPLANTATION [J].
FARRUGIA, E ;
SCHWAB, TR .
MAYO CLINIC PROCEEDINGS, 1992, 67 (09) :879-890
[2]   PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS ANTIBODY-POSITIVE RENAL-TRANSPLANT RECIPIENTS - A RANDOMIZED CONTROLLED TRIAL [J].
HIBBERD, PL ;
TOLKOFFRUBIN, NE ;
CONTI, D ;
STUART, F ;
THISTLETHWAITE, JR ;
NEYLAN, JF ;
SNYDMAN, DR ;
FREEMAN, R ;
LORBER, MI ;
RUBIN, RH .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) :18-26
[3]   SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL-TRANSPLANT RECIPIENT TREATED WITH OKT3 [J].
HIBBERD, PL ;
TOLKOFFRUBIN, NE ;
COSIMI, AB ;
SCHOOLEY, RT ;
ISAACSON, D ;
DORAN, M ;
DELVECCHIO, A ;
DELMONICO, FL ;
AUCHINCLOSS, H ;
RUBIN, RH .
TRANSPLANTATION, 1992, 53 (01) :68-72